VG-202

N/A

Report date: 2022/06/24 17:29:56

Base Information

Drug NameVG-202
Drug Alias NameVG-202
ClassificationCell and gene therapy > Gene therapyBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-12 stimulantsInterleukin-15 stimulantsInterleukin-15 receptor subunit alpha stimulants
TargetsInterleukin-12Interleukin-15Interleukin-15 receptor subunit alpha
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViroGin Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViroGin Biotech Ltd
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A